Widespread Use of GLP-1 Drugs for Diabetes and Weight Loss Revealed by KFF Survey
A recent survey conducted by the Kaiser Family Foundation (KFF) has uncovered that approximately one in eight adults in the United States has at some point used a GLP-1 receptor agonist, such